A French subcontractor will start producing "in March" the Moderna vaccine against Covid-19, and another will launch "in April" the production of that of Pfizer / BioNTech, announced Wednesday on RTL the Minister Delegate for Industry Agnès Pannier-Runacher.
Tuesday evening, Emmanuel Macron announced that the production of vaccines on French soil would begin "from the end of February, the beginning of March", after a meeting with the major French and European laboratories.
The President of the Republic had indicated that four production sites would participate in the creation of vaccines developed by other laboratories, including three French subcontractors.
In November and December, Delpharm had already announced that it would produce the Pfizer / BioNTech vaccine at its Normandy plant, Recipharm the Moderna vaccine in Monts, Indre-et-Loire, and Fareva the CureVac vaccine at its sites in Pau and Val -de-Reuil.
"The first production site to start will be in March for the Moderna vaccine," Agnès Pannier-Runacher said on Wednesday morning.
"We will have a production site which will then start in April, it will be for the Pfizer / BioNTech vaccine. And in May, it should be for the CureVac vaccine, there we are waiting for the marketing authorization, so I put a conditional, ”she added.
The minister indicated that the French laboratory Sanofi - which has postponed the release of its own vaccine to the second half of 2021 - "will for its part also produce".
"We have worked with them so that they produce BioNTech vaccine in their German factory, this will help to move up production chains. If their vaccine has positive results, in April, they will also start production", detailed Agnès Pannier-Runacher.
© 2021 AFP